** Shares of Epsilon Healthcare EPN.AX rise as much as
18.9% to A$0.063, posting its biggest intraday gain since
November 2021
** The pharma co said it has formalised its partnership with
Canada-based cannabis firm The Valens Company VLNS.TO
urn:newsml:reuters.com:*:nFWN2V51PB
** Co says it plans A$2 mln ($1.46 million)sales target of
medicinal cannabis products to Valens customers over a
three-month trial period
** As of last close, stock is down 25.4%so far this year
($1 = 1.3716 Australian dollars)
(Reporting by Navya Mittal in Bengaluru)
((navya.mittal@thomsonreuters.com))